Research Article
Role of Paricalcitol in Modulating the Immune Response in Patients with Renal Disease
Table 3
Univariate and multiple regression analysis of NGAL in CKD patients.
(a) In vivo | ||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||
(b) In vitro | ||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||
Dependent variable: NGAL; β: standardized coefficient of correlation. NGAL: neutrophil gelatinase associated lipocalin; IL-17: interleukin-17; IL-6: interleukin-6; IL-1β: interleukin-1 beta; IFN-γ: interferon-gamma; TNF-α: tumor necrosis factor-alpha; hsCRP: high-sensitivity C-reactive protein; ESR: erythrocyte sedimentation rate. |